Pro00021750: Clin/Neurocognitive Outcomes

Clinical Trials for Adults  | Clinical and Neurocognitive Outcomes in Long-term Survivors of Primary Glioblastoma Multiforme

Primary Objective
To measure neurocognitive function in long-term survivors of primary GBM

Secondary Objectives

  • to examine patient-reported measures (i.e. quality of life, fatigue, etc.)
  • to identify patterns in retrospective neuropsychological testing from standardized neuropsychological testing batteries
  • to identify tumor-related information (i.e. tumor location, number of recurrences, etc.)
  • to identify clinical characteristics (i.e. neurological deficits, psychiatric illness, etc.)
  • to identify image cytometry profiles






This article comes from The Preston Robert Tisch Brain Tumor Center at Duke   http://www.cancer.duke.edu/btc
The URL for this story is:   http://www.cancer.duke.edu/btc/modules/ClinicalTrials4/index.php?id=108